Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for TRML

Stock NameTourmaline Bio Inc.
TickerTRML(USD) NASDAQ
TYPECommon Stock
CountryUSA

Show aggregate TRML holdings

News associated with TRML

Truist Financial Downgrades Tourmaline Bio (NASDAQ:TRML) to Hold
Tourmaline Bio (NASDAQ:TRML – Get Free Report) was downgraded by equities research analysts at Truist Financial from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. They presently have a $48.00 price target on the stock, down from their previous price target of […] - 2025-09-11 05:14:52
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 13:24:04
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 11:56:00
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 10:14:58
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 08:35:12
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 06:54:32
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 03:39:30
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $50.14 Average Target Price from Analysts
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight analysts that are presently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average […] - 2025-09-10 02:32:51
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 00:27:19
Stocks Edge Higher on Expectations for Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.07%, and September E-mini Nasdaq futures... - 2025-09-09 14:59:32
Stocks Turn Mixed as US Job Growth Less Than Previously Stated
The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.08%. September E-mini S&P futures (ESU25 ) are down -0.08%, and September E-mini Nasdaq futures... - 2025-09-09 14:45:23
Stocks Edge Higher on Expectations for Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.07%, and September E-mini Nasdaq futures... - 2025-09-09 12:48:35
Tourmaline Bio Agrees To Be Acquired By Novartis In $1.4 Bln Deal; Stock Up
(RTTNews) - Tourmaline Bio Inc. (TRML) announced Tuesday that it has agreed to be acquired by Novartis AG (NVS, NOVN.SW) for $48.00 per share in cash at closing, representing a total equity value of about $1.4 billion. The deal price represents a premium of 59% to Tourmalines clo - 2025-09-09 02:28:03
Federated Hermes Inc. Buys 120,322 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)
Federated Hermes Inc. increased its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 13,036.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 121,245 shares of the company’s stock after acquiring an additional 120,322 shares during the quarter. Federated Hermes Inc.’s […] - 2025-08-06 05:13:00
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $49.33 Consensus PT from Analysts
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has received an average rating of “Buy” from the seven analysts that are presently covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have covered the stock in the last […] - 2025-06-27 02:37:04
GAMMA Investing LLC Grows Stake in Tourmaline Bio, Inc. (NASDAQ:TRML)
GAMMA Investing LLC grew its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 4,481.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 7,514 shares of the company’s stock after acquiring an additional 7,350 shares during the quarter. GAMMA Investing LLC’s holdings in Tourmaline Bio were worth $114,000 at the […] - 2025-06-24 04:46:55
SG Americas Securities LLC Has $550,000 Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML)
SG Americas Securities LLC lifted its position in Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 3.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,180 shares of the company’s stock after buying an additional 1,368 shares during the quarter. SG Americas […] - 2025-06-23 04:58:58
California State Teachers Retirement System Has $213,000 Stake in Tourmaline Bio, Inc. (NASDAQ:TRML)
California State Teachers Retirement System increased its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 527.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 10,505 shares of the company’s stock after buying an additional 8,832 shares during the quarter. California State Teachers Retirement System’s holdings in Tourmaline Bio were […] - 2025-06-13 05:02:51
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $49.33 Consensus PT from Brokerages
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have issued ratings on the stock in the […] - 2025-06-02 03:09:00
Millennium Management LLC Has $7.40 Million Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML)
Millennium Management LLC lowered its position in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 28.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 364,658 shares of the company’s stock after selling 144,757 shares during the quarter. Millennium […] - 2025-05-27 04:48:57
Head-To-Head Analysis: Tourmaline Bio (NASDAQ:TRML) vs. enGene (NASDAQ:ENGN)
Tourmaline Bio (NASDAQ:TRML – Get Free Report) and enGene (NASDAQ:ENGN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Institutional & Insider Ownership 91.9% of Tourmaline Bio […] - 2025-05-14 02:20:48
Analysts Set Tourmaline Bio, Inc. (NASDAQ:TRML) Target Price at $49.33
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been assigned a consensus rating of “Buy” from the seven brokerages that are covering the firm, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have covered the stock in the last […] - 2025-05-08 02:04:55
Barclays PLC Acquires 26,733 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)
Barclays PLC grew its holdings in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 84.0% during the fourth quarter, Holdings Channel reports. The firm owned 58,566 shares of the company’s stock after purchasing an additional 26,733 shares during the period. Barclays PLC’s holdings in Tourmaline Bio were worth $1,187,000 as of its most […] - 2025-05-05 05:18:49
Tourmaline Bio (NASDAQ:TRML) Earns Buy Rating from Analysts at Chardan Capital
Stock analysts at Chardan Capital began coverage on shares of Tourmaline Bio (NASDAQ:TRML – Get Free Report) in a report issued on Wednesday, Marketbeat reports. The brokerage set a “buy” rating and a $70.00 price target on the stock. Chardan Capital’s price objective would indicate a potential upside of 304.16% from the company’s current price. […] - 2025-04-25 04:24:47
Vanguard Group Inc. Acquires 43,652 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)
Vanguard Group Inc. boosted its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 4.1% in the 4th quarter, HoldingsChannel reports. The fund owned 1,106,125 shares of the company’s stock after buying an additional 43,652 shares during the quarter. Vanguard Group Inc.’s holdings in Tourmaline Bio were worth $22,432,000 at the end […] - 2025-04-16 04:28:51
Head to Head Survey: Tourmaline Bio (NASDAQ:TRML) vs. Vaxcyte (NASDAQ:PCVX)
Vaxcyte (NASDAQ:PCVX – Get Free Report) and Tourmaline Bio (NASDAQ:TRML – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Profitability This table compares Vaxcyte and Tourmaline Bio’s net […] - 2025-02-21 04:34:51

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) TRML holdings

DateNumber of TRML Shares HeldBase Market Value of TRML SharesLocal Market Value of TRML SharesChange in TRML Shares HeldChange in TRML Base ValueCurrent Price per TRML Share HeldPrevious Price per TRML Share Held
2025-10-27 (Monday)16,223USD 778,380USD 778,3800USD 0 USD 47.98 USD 47.98
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TRML by Blackrock for IE00BYXG2H39

Show aggregate share trades of TRML

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-20BUY8447.93047.945 47.943USD 4,027 21.71
2025-10-17BUY21047.90047.920 47.918USD 10,063 21.59
2025-10-15BUY33647.89047.920 47.917USD 16,100 21.47
2025-10-09BUY48047.85047.920 47.913USD 22,998 21.12
2025-10-06BUY12647.87047.900 47.897USD 6,035 20.87
2025-10-03BUY29447.90047.900 47.900USD 14,083 20.75
2025-10-02BUY4247.87047.940 47.933USD 2,013 20.63
2025-09-30BUY8447.83047.900 47.893USD 4,023 20.37
2025-09-26BUY8447.74047.765 47.762USD 4,012 20.12
2025-09-25BUY8447.72047.770 47.765USD 4,012 19.99
2025-09-24SELL-70847.75047.760 47.759USD -33,813 19.86 Loss of -19,755 on sale
2025-09-18BUY4447.69047.770 47.762USD 2,102 19.72
2025-09-17BUY13547.70047.750 47.745USD 6,446 19.59
2025-09-11SELL-4447.60047.640 47.636USD -2,096 19.05 Loss of -1,258 on sale
2025-09-10BUY8847.60047.640 47.636USD 4,192 18.91
2025-09-05SELL-4526.74028.455 28.283USD -1,273 18.67 Loss of -433 on sale
2025-08-29SELL-13523.40023.420 23.418USD -3,161 18.57 Loss of -655 on sale
2025-08-27BUY9023.51524.560 24.455USD 2,201 18.52
2025-08-26SELL-4523.50523.580 23.572USD -1,061 18.49 Loss of -229 on sale
2025-08-25BUY4522.68023.520 23.436USD 1,055 18.47
2025-08-20SELL-18022.46022.750 22.721USD -4,090 18.43 Loss of -773 on sale
2025-08-18BUY9022.17022.845 22.777USD 2,050 18.39
2025-08-08SELL-9020.72021.670 21.575USD -1,942 18.30 Loss of -295 on sale
2025-08-05BUY4422.42022.930 22.879USD 1,007 18.24
2025-08-01SELL-13221.76022.340 22.282USD -2,941 18.20 Loss of -539 on sale
2025-07-30BUY17623.34023.810 23.763USD 4,182 18.15
2025-07-17SELL-9018.60018.930 18.897USD -1,701 18.07 Loss of -74 on sale
2025-07-11SELL-36017.98018.080 18.070USD -6,505 18.06 Loss of -4 on sale
2025-07-07BUY13515.96016.380 16.338USD 2,206 18.09
2025-07-02BUY2,47516.19016.500 16.469USD 40,761 18.13
2025-06-25BUY9016.99017.230 17.206USD 1,549 18.17
2025-06-11BUY9019.09519.900 19.819USD 1,784 18.18
2025-06-10BUY9019.00019.120 19.108USD 1,720 18.17
2025-06-04SELL-4618.73019.350 19.288USD -887 18.15 Loss of -52 on sale
2025-04-23BUY4517.82018.406 18.348USD 826 18.69
2025-04-10SELL-36812.10012.550 12.505USD -4,602 19.02 Profit of 2,399 on sale
2025-04-08SELL-4512.22013.400 13.282USD -598 19.16 Profit of 264 on sale
2025-04-07SELL-4512.62013.270 13.205USD -594 19.23 Profit of 271 on sale
2025-04-04SELL-23012.83013.120 13.091USD -3,011 19.29 Profit of 1,427 on sale
2025-04-01BUY18414.24015.180 15.086USD 2,776 19.41
2025-03-31SELL-13815.21016.220 16.119USD -2,224 19.45 Profit of 460 on sale
2025-03-21BUY1,28417.15017.460 17.429USD 22,379 19.62
2025-03-14SELL-67218.80018.820 18.818USD -12,646 19.75 Profit of 626 on sale
2025-03-07SELL-8414.38015.660 15.532USD -1,305 20.01 Profit of 377 on sale
2025-03-04SELL-4212.42012.760 12.726USD -534 20.29 Profit of 318 on sale
2025-02-25BUY8412.55012.720 12.703USD 1,067 20.84
2025-02-19SELL-4212.60013.090 13.041USD -548 21.36 Profit of 349 on sale
2025-02-13BUY12613.09013.745 13.679USD 1,724 21.88
2025-02-12BUY4213.23013.250 13.248USD 556 22.02
2025-02-11BUY16812.88013.760 13.672USD 2,297 22.17
2025-01-17BUY16418.00018.195 18.175USD 2,981 24.48
2025-01-16BUY16417.33018.540 18.419USD 3,021 24.66
2025-01-10SELL-8219.70020.210 20.159USD -1,653 25.27 Profit of 419 on sale
2025-01-08SELL-16420.00020.350 20.315USD -3,332 25.57 Profit of 861 on sale
2024-12-30SELL-2,18220.08020.460 20.422USD -44,561 25.88 Profit of 11,917 on sale
2024-11-18SELL-70524.52025.730 25.609USD -18,054 27.22 Profit of 1,133 on sale
2024-11-08SELL-4728.76029.545 29.467USD -1,385 27.18 Loss of -107 on sale
2024-10-21SELL-4728.30528.795 28.746USD -1,351 0.00 Loss of -1,351 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TRML

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1943,83734100,25143.7%
2025-09-1867,782131487,08613.9%
2025-09-1776,55511180,55442.4%
2025-09-1629,51333398,58129.9%
2025-09-1570,03461229,95530.5%
2025-09-1268,336128223,15430.6%
2025-09-11108,0551,447313,82434.4%
2025-09-10107,2215,190545,01019.7%
2025-09-092,215,9937,8868,384,88026.4%
2025-09-08137,88267328,34942.0%
2025-09-0594,1120199,58247.2%
2025-09-0489,1830120,77673.8%
2025-09-0388,5750113,16578.3%
2025-09-0249,504056,25688.0%
2025-08-2942,240049,47385.4%
2025-08-2820,280428,86570.3%
2025-08-2738,845052,65073.8%
2025-08-2631,462042,61873.8%
2025-08-2516,134021,95273.5%
2025-08-2223,826036,71564.9%
2025-08-2124,85970139,32263.2%
2025-08-2014,5521824,24460.0%
2025-08-1926,999034,33278.6%
2025-08-1886,63512124,81669.4%
2025-08-1515,3844732,47847.4%
2025-08-1421,14315037,70256.1%
2025-08-1325,77817838,03267.8%
2025-08-1230,0792946,95864.1%
2025-08-1125,11012105,20623.9%
2025-08-0832,9961,08593,34535.3%
2025-08-0742,833054,08479.2%
2025-08-0635,063068,01151.6%
2025-08-0529,4801646,58563.3%
2025-08-0419,5487371,73627.2%
2025-08-0142,5622887,35548.7%
2025-07-3172,28856135,59053.3%
2025-07-3060,32420295,90262.9%
2025-07-29312,855233432,37472.4%
2025-07-2895,69751250,79538.2%
2025-07-2549,67316115,22743.1%
2025-07-2426,07937491,33428.6%
2025-07-2317,642046,23338.2%
2025-07-2214,46034827,16453.2%
2025-07-2118,96620324,32778.0%
2025-07-1819,195040,33847.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.